SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001005477-05-003164
Filing Date
2005-09-08
Accepted
2005-09-08 15:43:38
Documents
2
Period of Report
2005-01-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 edgar123.html 4  
1 FORM 4 edgar123.xml 4 6196
2 lebuhn.htm EX-24 6893
  Complete submission text file 0001005477-05-003164.txt   15053
Mailing Address C/O DORSEY & WHITNEY LLP 250 PARK AVE NEW YORK NY 10177
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 7329804500
ENZON PHARMACEUTICALS INC (Issuer) CIK: 0000727510 (see all company filings)

IRS No.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 222 S 15TH STREET SUITE 600 N OMAHA NE 68102
Business Address
LEBUHN ROBERT (Reporting) CIK: 0001007931 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-12957 | Film No.: 051075303